top of page

- Oct 11, 2023

The Head of Bayer in the US on pharma and a new $250M cell Tx facility in Berkeley, CA. #HLTH2023

Sebastian Guth discusses areas of focus for Bayer like oncology, cardiovascular disease, and women's health, and platforms such as radiopharmaceuticals and cell therapies. He also talks about investing in a new 100,000 square foot cell therapy manufacturing plant in Berkeley, CA.

Recent Posts

The founder of Entos Pharmaceuticals describes trying to design a delivery vehicle that's better than AAV and LNPs by harnessing fusogens

Merck KGaA's head of global R&D and CMO gives an overview of the company's programs and its appetite for business development

London's Epsilogen completed a £12.5 million Series B expansion this week to take its IgE based folate receptor alpha program into a phase 1b study

Comments

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

NYSE_logo_large_no reg_378x197 (1).png

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

bottom of page